ACAAI 2023 Allergen Extract Mixing Course

August 5, 2023

Price: $369 for members, $469 for non-members

NOTE: Only registered participants will be admitted to the 2023 Allergen Extract Mixing Course on August 5. Walk-ins and non-registrants will be turned away.

This stand-alone, one day, hands-on workshop is being held on August 5, 2023 at the Chicago O'Hare Airport Hilton. It is geared to train physicians and allied health professionals how to appropriately mix allergen extracts for use with their patients. Participants must comply with USP Chapter 797 which includes detailed procedures and ensures the extracts do not get contaminated. This robust course provides didactics followed by a substantial “hands on” component.

Refunds are available (minus $75 administration fee) if your cancellation request is received via email ( on or before July 5, 2023. Cancellations requests received
after July 5 are not eligible for a refund. The College is not responsible for hotel cancellations. Please contact the O'Hare Hilton at (877) 865-5322. 

Because the course is designed to be a hands-on experience, a virtual version will not be offered.

Questions about the course? E-mail  for more information.

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 5.5 contact hours. 

Commercial Support
This program is supported by an independent education grant from Stallergenes Greer.

Target Audience

Allergy and immunology physicians and their staff responsible for allergen extract preparation

Learning Objectives

  1. Identify the key changes to the allergen mixing environment and cutting-edge research to advance immunotherapy.
  2. Discuss the preparation of an allergen extract kit to include selection of allergens, diluents, and allergen standardization.
  3. Implement the USP Chapter 797 guidelines for the preparation of allergen extract treatment sets and provide resources to assist allergy practices in meeting the requirements.
  4. Demonstrate the important tests needed to meet USP 797 standards to include the media fill test and glove tip test.
Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Bryan Martin, MD, ALK: Advisor

Michael Nelson, MD, Sanofi: Researcher; Stock/stock options: Alnylam Pharmaceuticals Inc Astrazeneca, Horizon Therapeutics, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Royalty Pharma

Maureen Petersen, MD, nothing to disclose

Sarah Spriet, DO, nothing to disclose

James L. Sublett, MD, Speaker: GlaxoSmithKline

Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Attendance
  • 5.50 CBRN
Course opens: 
Course expires: 
Event starts: 
08/05/2023 - 9:00am CDT
Event ends: 
08/05/2023 - 3:00pm CDT
Hilton Chicago O'Hare
Chicago 60666
United States
+1 (877) 865-5322

Hilton Chicago O’Hare Airport
Hotel Room Rate:  $129 / night + 17.40% tax
Register Online:
Register by Phone:  1-877-865-5322 (Mention Code: 93F to receive the group rate)

The deadline for hotel reservation is Friday, July 21, 2023
Hotel reservations / rate availability are not guaranteed after the room block is full or after July 21, 2023.  Please register early, as only a limited number of rooms are available.

Maureen M. Petersen, MD, FACAAI - Course Director, Planner, Faculty
Dr. Petersen is the Director of Medical Education at Walter Reed National Military Medical Center in Bethesda, MD.  She obtained her BS in Biology from the College of William and Mary and then graduated from the Uniformed Services University of the Health Sciences in Bethesda, MD.  She completed her internship and residency in pediatrics at Tripler Army Medical Center in Hawaii.  Dr. Petersen worked as a general pediatrician at Walter Reed Army Medical Center (WRAMC) in Washington, DC and completed her allergy-immunology fellowship at WRAMC. Dr. Petersen holds the faculty positions of associate professor of pediatrics and internal medicine at the Uniformed Services University of the Health Sciences and has been received several teaching awards.

Michael Nelson, MD, PhD, FACAAI - Planner, Faculty
Dr. Nelson is the President of the American Board of Allergy and Immunology, a member of the American Board of Medical Specialties (ABMS) Board of Directors and Executive Committee, and Chief of the Asthma, Allergy and Immunology Division at the University of Virginia. Dr. Nelson received his MD and PhD in Pharmacology from the University of Virginia before entering active duty military service.  He has served as a Program Director, Department Chief, Medical Director of the United States Army Centralized Allergen Extract Laboratory, Director of Army Graduate Medical Education and Chief Consultant to the U.S. Army Surgeon General, Director of Education, Training and Research at Walter Reed National Military Medical Center and vice chair of the ACGME Allergy and Immunology Review Committee. 

Sarah Spriet, DO, FACAAI - Planner, Faculty
Dr. Spriet is a Clinical Associate Professor of Pediatrics and Medicine at the Medical College of Georgia (MCG) at Augusta University. Dr. Spriet completed her fellowship training at Walter Reed National Military Center. She served as the ACAAI National FIT Representative from 2014-2016 and has served on several College committees since then. After serving on the fellowship training program at Walter Reed National Military Medical Center, Dr. Spriet joined the faculty at MCG in 2022 after competing over ten years of Active-Duty Army service.  Her clinical and research interests include allergen immunotherapy, drug allergy, venom hypersensitivity, allergic skin diseases and health professions education.

James L. Sublett, MD, FACAAI - Planner, Faculty
Dr. Sublett is a Past President of the American College of Allergy, Asthma & Immunology (ACAAI) and currently serves as the College’s Executive Director for Advocacy and Governmental Affairs. In this capacity, he was on point for the College representing the practicing allergists during the last revisions of USP <797> related to the compounding of extract vials for allergen immunotherapy. He has been honored by the College as a Distinguished Fellow and recently the Golden Headed Cane Lifetime Achievement Award. Dr. Sublett is the Co-Founder and Chief Medical Officer of Family Allergy & Asthma. Based in Louisville, KY, (USA) FAA is a multi-state practice with 96 allergists and 25 advanced practitioners with 107 offices in Arkansas, Florida, Indiana, Illinois, Kentucky, Missouri, Ohio, Pennsylvania, and Tennessee. He is also a Fellow of the American Academy of Allergy, Asthma, & Immunology. He serves on the Board of the World Allergy Organization and the Editorial Board of the WAO Journal. In addition, Dr. Sublett is on several other boards, including the University of Louisville President’s Council and the Norton Healthcare Board of Trustees.  He is a Clinical Professor at the University of Louisville School of Medicine and for over 20 years served as the Section Chief of Pediatric Allergy & Immunology.

Bryan L. Martin, DO, MMAS, FACAAI - Planner, Faculty
Dr. Martin is a Past President of the American College of Allergy, Asthma and Immunology (ACAAI) and is currently the President of the World Allergy Organization (WAO). He was most recently at The Ohio State University where he served as a Professor of Medicine and Pediatrics, Associate Dean for Graduate Medical Education, the Designated Institutional Official and the Associate Medical Director for University Hospitals, as well as the program director in Allergy and Immunology and as Chief of the Allergy Immunology Division. Prior to his service at Ohio State, Dr. Martin spent 29 years in the US Army. Active in Organized Medicine at all levels, Dr. Martin is the past Chair of the International Collaboration in Asthma, Allergy and Immunology (iCAALL), and past Chair of the Accreditation Council for Graduate Medical Education (ACGME) Allergy and Immunology Residency Review Committee and also served on the Board of Directors of the Joint Council of Allergy, Asthma and Immunology, and as a member of the Food and Drug Administration Allergenic Products Advisory Committee. Dr. Martin has been honored by the College as a Distinguished Fellow, and has won other prestigious awards such as the Accreditation Council for Graduate Medical Education Courage to Teach Award, the US Army’s Lewis Aspey Mologne Award for Military Academic Excellence and the 2022  the State of Ohio Veterans Hall of Fame.

Available Credit

  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Attendance
  • 5.50 CBRN


Please login or create an account to take this course.